Neuropsychiatric biomarker discovery: go big or go home
- PMID: 37714797
- PMCID: PMC10879988
- DOI: 10.1016/j.molmed.2023.09.002
Neuropsychiatric biomarker discovery: go big or go home
Abstract
Technological advances have enabled high-throughput omics assays, such as parallelized screening of lipids across plasma samples. Pioneering a new paradigm for neuropsychiatric biomarker discovery, Yap et al. describe a large-scale systematic analysis of comprehensive phenotypic, genotypic, environmental, and lipidomic data to unravel the intricate interplay between these and autism-associated traits.
Keywords: biomarkers; lipidomics; neuropsychiatry; omics.
Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of interests S.J.S. receives research funding from BioMarin Pharmaceutical.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
